Visual Abstract: Effect of Camrelizumab With Chemotherapy on Esophageal Squamous Cell Carcinoma

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 14, 2021

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.12836?guestAccessKey=c8164586-8683-46b1-b6a4-32216d267f7c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091421

 

Visual Abstract

 

Authors: Rui-Hua Xu, M.D., Ph.D., of the Collaborative Innovation Center for Cancer Medicine in Guangzhou, China, is the corresponding author.

(doi:10.1001/jama.2021.12836)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.